Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: A comparison between two different daily doses of lansoprazole

World Journal of Gastroenterology

Volumn 12, Issue 1, 2006, Pages 82-88

  Baldi, Fabio ^a   Cappiello, Roberta ^a   Cavoli, Carlotta ^a   Ghersi, Stefania ^a   Torresan, Francesco ^a   Roda, Enrico ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cough; Gastroesophageal reflux; Lansoprazole; Proton pump inhibitors

Indexed keywords

LANSOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 31144448688     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i1.82     Document Type: Article

References (31)

1. Richter JE. Extraesophageal presentations manifestations of gastroesophageal reflux disease. Semin Gastrointest Gastroenterol Dis 1997; 8: 75-89
2. Irwin RS, Richter JE. Gastroesophageal reflux and chronic cough. Am J Gastroenterol 2000; 95: S 9-S14
3. Irwin RS, Curley FJ, French CL. Chronic cough: The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141: 640-647
4. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131-3138
5. Kiljander TO, Salomaa ERM, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000; 16: 633-638
6. El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-983
7. Armstrong D, Blum AL, Savary M. Reflux disease and Barrett's oesophagus. Endoscopy 1992; 24: 9-17
8. Baldi F, Ferrarini F, Longanesi A. Ambulatory 24-hour esophageal pH monitoring in normal subjects: a multicentre study in Italy. Ital J Gastroenterol 1991; 23: 477-480
9. Singh S, Richter JE, Bradley LA, Haile JM. The Ssymptom Indexindex: differential Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 1993; 38: 1402-1408
10. Nyren O, Adami HO, Bates S, Bergstrom R, Gustavsson S, Loof L, Sjoden PO. Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol 1987; 9: 408-414
11. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4rdEdition. Oxford: Blackwell Scientific Publications, 2002
12. Young JL, Shaw GY, Searl JP, Miner PB Jr. Laryngeal manifestations of gastroesophageal reflux disease: endoscopic appearance and management. Gastrointest Endosc 1996; 43: 225-230
13. Larrain A, Carrasco E, Galleguillos F, Sepulveda R, Pope CE 2nd. Medical and surgical treatment of non-allergic asthma associated with gastroesophageal reflux. Chest 1991; 99: 1330-1335
14. Sontag SJ, Schnell TG, Miller TQ, Khandelwal S, O'Connell S, Chejfec G, et al. Prevalence of oesophagitis in asthmatics. Gut 1992; 33: 872-876
15. Richter JE, Hicks DM. Unresolved issues in gastroesophageal reflux-related ear, nose and throat problems. Am J Gastroenterol 1997; 92: 2143-2144
16. Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, Albertucci M. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111
17. Sontag SJ, O'Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990; 99: 613-620
18. Schnatz PF, Castell JA, Castell DO. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 1996; 91: 1715-1718
19. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): Aa clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1-78
20. Vaezi MF, Richter JE. Twenty-four-hour ambulatory esophageal pH monitoring in the diagnosis of acid reflux-related chronic cough. South Med J 1997; 90: 305-311
21. Hewson EG, Sinclair JW, Dalton CB, Richter JE. 24-Twenty-Four-Hour esophageal pH-monitoring. The most useful test for evaluating non-cardiac chest pain. Am J Med 1991; 90: 576-583
22. Breumelhof R, Smout AJPM. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991; 86: 160-164
23. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997-2000
24. Fass R, Fennerty MB, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42-49
25. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One- week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15-20
26. Fass R, Ofman JJ, Sampliner RE, Camargo LE, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux -disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000; 14: 389-396
27. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol 2005; 100: 1226-1232
28. Juul-Hansen P, Rydning A, Jacobsen CD, Hansen T. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 2001; 36: 806-810
29. Pandak WM, Arezo S, Everett S, Jesse R, DeCosta G, Crofts T, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol 2002; 35: 307-314
30. Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997; 116: 41-46
31. Jaspersen D, Diehl KL, Geyer P, Martens E. Diagnostic omeprazole test in suspected reflux-associated chronic cough. Pneumologie 1999; 5: 438-441